These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4756424)

  • 41. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of D-penicillamine for the treatment of rheumatoid arthritis and the study of various mechanisms of its action].
    Trofimova TM; Panasiuk AF; Avdeeva ZhI; Tarasenkova TA; Astakhova TA
    Ter Arkh; 1980; 52(6):110-3. PubMed ID: 7404375
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effectiveness of D-penicillamine as the main therapeutic agent in rheumatoid arthritis].
    Otto V; Petrushka VD; Binken O
    Vopr Revm; 1976; (3):31-3. PubMed ID: 997425
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of cuprenil (D-penicillamine) treatment on the clinical course of rheumatoid arthritis].
    Małdykowa H; Chwalińska-Sadowska H; Zajzczek-Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T
    Reumatologia; 1981; 19(2):189-95. PubMed ID: 7034105
    [No Abstract]   [Full Text] [Related]  

  • 46. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 51. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis.
    Mbuyi-Muamba JM; Stevens E; Dequeker J
    Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.
    Yu TF; Roboz J; Johnson S; Kaung C
    J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
    [No Abstract]   [Full Text] [Related]  

  • 55. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nursing care of outpatients taking penicillamine as a trial drug in the treatment of rheumatoid arthritis.
    Langstaff SR
    Nurs Times; 1975 Jun; 71(24):920. PubMed ID: 1134976
    [No Abstract]   [Full Text] [Related]  

  • 58. [D-penicillamine in the treatment of rheumatism. Its value and side-effects. A discussion by international experts. Berlin].
    Z Rheumatol; 1988; 47 Suppl 1():1-54. PubMed ID: 3213268
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pyrithioxin in the treatment of patients with rheumatoid arthritis (comparative study with D-penicillamine)].
    Tosković B
    Reumatizam; 1983; 30(3):60-8. PubMed ID: 6351211
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis].
    Brenner S; Caspi D; Tchetchik R; Krakowski A; Yaron M
    Harefuah; 1983 Feb; 104(3):94-6. PubMed ID: 6618302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.